Featured Research

from universities, journals, and other organizations

Strong Demand For HIV Meds After High-risk Sex

Date:
November 12, 2007
Source:
University of California - Los Angeles
Summary:
People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full month-long drug regimen, according to a new study. Moreover, there is a strong demand for publicly available post-exposure prophylaxis among high-risk populations. Based on these findings, the researchers recommend that post-exposure HIV prophylaxis be made available to citizens who have engaged in high-risk sex.

People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full monthlong drug regimen, according to a new UCLA AIDS Institute study. Moreover, there is a strong demand for publicly available post-exposure prophylaxis among high-risk populations in Los Angeles County.

Based on these findings, the researchers recommend that Los Angeles County make post-exposure HIV prophylaxis available to citizens who have engaged in high-risk sex, just as it has for health care workers who inadvertently find themselves at risk due to accidental needle sticks.

"We frame this as a social justice issue. People with means and health insurance plans do get post-exposure prophylaxis because they can pay for it," said Steven Shoptaw, professor of family medicine and psychiatry at the David Geffen School of Medicine at UCLA and a member of the UCLA AIDS Institute. "It is our belief that we have a responsibility to provide that level of protection to all our citizens. These data show that when this kind of prevention is made available, the at-risk community will access and use it."

Researchers based their conclusions on a study that followed 100 people who received HIV medications following unprotected, very high-risk sex. Each participant was given 28 days worth of lamivudine and zidovudine, as well as HIV tests and physical examinations, and was scheduled for a follow-up visit 26 weeks later. Participants were highly educated in general, 63 percent were gay and 95 percent were male.

Of the participants, 75 percent completed the monthlong drug treatment and none were found to have converted to HIV-positive status, the researchers said. Given that such a high percentage of patients completed the full drug regimen, UCLA researchers concluded that it would be feasible to develop a post-exposure prophylaxis plan for at-risk populations that could be implemented through Los Angeles County.

"We have 2,000-plus HIV infections in this county every year, and that rate has been stable for a number of years, which signifies that behavioral prevention has reached its peak," Shoptaw said. "Having post-exposure prophylaxis available may provide another arrow in the quiver to prevent new HIV infections."

The study is available on the website of the journal AIDS Care for free to nonsubscribers through Dec. 31. In addition to Shoptaw, study authors were Erin Rotheram-Fuller, Jason Wang, Ardis Moe, Raphael J. Landovitz and Cathy Reback of UCLA, and David E. Kanouse of the RAND Corp. Shoptaw is also affiliated with the Baltimore-based Friends Research Institute, and Reback is associated with the Van Ness Recovery House Prevention Division in Los Angeles.


Story Source:

The above story is based on materials provided by University of California - Los Angeles. Note: Materials may be edited for content and length.


Cite This Page:

University of California - Los Angeles. "Strong Demand For HIV Meds After High-risk Sex." ScienceDaily. ScienceDaily, 12 November 2007. <www.sciencedaily.com/releases/2007/11/071109100218.htm>.
University of California - Los Angeles. (2007, November 12). Strong Demand For HIV Meds After High-risk Sex. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2007/11/071109100218.htm
University of California - Los Angeles. "Strong Demand For HIV Meds After High-risk Sex." ScienceDaily. www.sciencedaily.com/releases/2007/11/071109100218.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Idaho Boy Helps Brother With Disabilities Complete Triathlon

Idaho Boy Helps Brother With Disabilities Complete Triathlon

Newsy (July 23, 2014) An 8-year-old boy helped his younger brother, who has a rare genetic condition that's confined him to a wheelchair, finish a triathlon. Video provided by Newsy
Powered by NewsLook.com
Thousands Who Can't Afford Medical Care Flock to Free US Clinic

Thousands Who Can't Afford Medical Care Flock to Free US Clinic

AFP (July 23, 2014) America may be the world’s richest country, but in terms of healthcare, the World Health Organisation ranks it 37th. Thousands turned out for a free clinic run by "Remote Area Medical" with a visit from the Governor of Virginia. Duration: 2:40 Video provided by AFP
Powered by NewsLook.com
Stone Fruit Listeria Scare Causes Sweeping Recall

Stone Fruit Listeria Scare Causes Sweeping Recall

Newsy (July 22, 2014) The Wawona Packing Company has issued a voluntary recall on the stone fruit it distributes due to a possible Listeria outbreak. Video provided by Newsy
Powered by NewsLook.com
Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Newsy (July 22, 2014) The 83 new genetic markers could open dozens of new avenues for schizophrenia treatment research. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins